Cargando…

High-throughput screening and validation of antibodies against synaptic proteins to explore opioid signaling dynamics

Antibodies represent powerful tools to examine signal transduction pathways. Here, we present a strategy integrating multiple state-of-the-art methods to produce, validate, and utilize antibodies. Focusing on understudied synaptic proteins, we generated 137 recombinant antibodies. We used yeast disp...

Descripción completa

Detalles Bibliográficos
Autores principales: Lemos Duarte, Mariana, Trimbake, Nikita A., Gupta, Achla, Tumanut, Christine, Fan, Xiaomin, Woods, Catherine, Ram, Akila, Gomes, Ivone, Bobeck, Erin N., Schechtman, Deborah, Devi, Lakshmi A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7900253/
https://www.ncbi.nlm.nih.gov/pubmed/33619305
http://dx.doi.org/10.1038/s42003-021-01744-8
_version_ 1783654187124391936
author Lemos Duarte, Mariana
Trimbake, Nikita A.
Gupta, Achla
Tumanut, Christine
Fan, Xiaomin
Woods, Catherine
Ram, Akila
Gomes, Ivone
Bobeck, Erin N.
Schechtman, Deborah
Devi, Lakshmi A.
author_facet Lemos Duarte, Mariana
Trimbake, Nikita A.
Gupta, Achla
Tumanut, Christine
Fan, Xiaomin
Woods, Catherine
Ram, Akila
Gomes, Ivone
Bobeck, Erin N.
Schechtman, Deborah
Devi, Lakshmi A.
author_sort Lemos Duarte, Mariana
collection PubMed
description Antibodies represent powerful tools to examine signal transduction pathways. Here, we present a strategy integrating multiple state-of-the-art methods to produce, validate, and utilize antibodies. Focusing on understudied synaptic proteins, we generated 137 recombinant antibodies. We used yeast display antibody libraries from the B cells of immunized rabbits, followed by FACS sorting under stringent conditions to identify high affinity antibodies. The antibodies were validated by high-throughput functional screening, and genome editing. Next, we explored the temporal dynamics of signaling in single cells. A subset of antibodies targeting opioid receptors were used to examine the effect of treatment with opiates that have played central roles in the worsening of the ‘opioid epidemic.’ We show that morphine and fentanyl exhibit differential temporal dynamics of receptor phosphorylation. In summary, high-throughput approaches can lead to the identification of antibody-based tools required for an in-depth understanding of the temporal dynamics of opioid signaling.
format Online
Article
Text
id pubmed-7900253
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-79002532021-03-05 High-throughput screening and validation of antibodies against synaptic proteins to explore opioid signaling dynamics Lemos Duarte, Mariana Trimbake, Nikita A. Gupta, Achla Tumanut, Christine Fan, Xiaomin Woods, Catherine Ram, Akila Gomes, Ivone Bobeck, Erin N. Schechtman, Deborah Devi, Lakshmi A. Commun Biol Article Antibodies represent powerful tools to examine signal transduction pathways. Here, we present a strategy integrating multiple state-of-the-art methods to produce, validate, and utilize antibodies. Focusing on understudied synaptic proteins, we generated 137 recombinant antibodies. We used yeast display antibody libraries from the B cells of immunized rabbits, followed by FACS sorting under stringent conditions to identify high affinity antibodies. The antibodies were validated by high-throughput functional screening, and genome editing. Next, we explored the temporal dynamics of signaling in single cells. A subset of antibodies targeting opioid receptors were used to examine the effect of treatment with opiates that have played central roles in the worsening of the ‘opioid epidemic.’ We show that morphine and fentanyl exhibit differential temporal dynamics of receptor phosphorylation. In summary, high-throughput approaches can lead to the identification of antibody-based tools required for an in-depth understanding of the temporal dynamics of opioid signaling. Nature Publishing Group UK 2021-02-22 /pmc/articles/PMC7900253/ /pubmed/33619305 http://dx.doi.org/10.1038/s42003-021-01744-8 Text en © The Author(s) 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Lemos Duarte, Mariana
Trimbake, Nikita A.
Gupta, Achla
Tumanut, Christine
Fan, Xiaomin
Woods, Catherine
Ram, Akila
Gomes, Ivone
Bobeck, Erin N.
Schechtman, Deborah
Devi, Lakshmi A.
High-throughput screening and validation of antibodies against synaptic proteins to explore opioid signaling dynamics
title High-throughput screening and validation of antibodies against synaptic proteins to explore opioid signaling dynamics
title_full High-throughput screening and validation of antibodies against synaptic proteins to explore opioid signaling dynamics
title_fullStr High-throughput screening and validation of antibodies against synaptic proteins to explore opioid signaling dynamics
title_full_unstemmed High-throughput screening and validation of antibodies against synaptic proteins to explore opioid signaling dynamics
title_short High-throughput screening and validation of antibodies against synaptic proteins to explore opioid signaling dynamics
title_sort high-throughput screening and validation of antibodies against synaptic proteins to explore opioid signaling dynamics
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7900253/
https://www.ncbi.nlm.nih.gov/pubmed/33619305
http://dx.doi.org/10.1038/s42003-021-01744-8
work_keys_str_mv AT lemosduartemariana highthroughputscreeningandvalidationofantibodiesagainstsynapticproteinstoexploreopioidsignalingdynamics
AT trimbakenikitaa highthroughputscreeningandvalidationofantibodiesagainstsynapticproteinstoexploreopioidsignalingdynamics
AT guptaachla highthroughputscreeningandvalidationofantibodiesagainstsynapticproteinstoexploreopioidsignalingdynamics
AT tumanutchristine highthroughputscreeningandvalidationofantibodiesagainstsynapticproteinstoexploreopioidsignalingdynamics
AT fanxiaomin highthroughputscreeningandvalidationofantibodiesagainstsynapticproteinstoexploreopioidsignalingdynamics
AT woodscatherine highthroughputscreeningandvalidationofantibodiesagainstsynapticproteinstoexploreopioidsignalingdynamics
AT ramakila highthroughputscreeningandvalidationofantibodiesagainstsynapticproteinstoexploreopioidsignalingdynamics
AT gomesivone highthroughputscreeningandvalidationofantibodiesagainstsynapticproteinstoexploreopioidsignalingdynamics
AT bobeckerinn highthroughputscreeningandvalidationofantibodiesagainstsynapticproteinstoexploreopioidsignalingdynamics
AT schechtmandeborah highthroughputscreeningandvalidationofantibodiesagainstsynapticproteinstoexploreopioidsignalingdynamics
AT devilakshmia highthroughputscreeningandvalidationofantibodiesagainstsynapticproteinstoexploreopioidsignalingdynamics